Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
3,960.00
+325.00 (8.94%)
Sep 11, 2024, 3:00 PM KST
-16.04% (1Y)
Market Cap | 182.55B |
Revenue (ttm) | -340.00 |
Net Income (ttm) | -33.11B |
Shares Out | 45.81M |
EPS (ttm) | -1,243.82 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 4,053,721 |
Open | 3,675.00 |
Previous Close | 3,635.00 |
Day's Range | 3,515.00 - 3,985.00 |
52-Week Range | 1,464.17 - 5,500.00 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 13, 2024 |